A Form 4 filed on September 4, 2026 with the U.S. Securities and Exchange Commission discloses that Tat Thuan Yen, VP of Finance of IM8 (US) LLC at Prenetics Global Ltd, was granted 10,730 Restricted Stock Units on September 3, 2026 under the company's 2022 Share Incentive Plan.

Key Highlights

  • Reporting person: Tat Thuan Yen, VP, Finance of IM8 (US) LLC, filed as an officer of Prenetics Global Ltd (NASDAQ:PRE).
  • Grant date: 10,730 Restricted Stock Units were acquired on September 3, 2026, at a price of $0.
  • Underlying security: Each RSU represents a contingent right to receive one Class A Ordinary Share, par value $0.0015 per share.
  • Vesting schedule: 3,576 RSUs vest on August 3, 2027; the remaining 7,154 RSUs vest in eight equal tranches beginning November 3, 2027 and ending August 3, 2029, each subject to continued service.
  • Expiration date: August 3, 2033, as reported in the filing.
  • Post-transaction holdings: The reporting person beneficially owns 10,730 derivative securities directly following the reported transaction.

RSU Grant Details for Prenetics Global VP of Finance

According to the filing, Tat Thuan Yen, identified as VP, Finance of IM8 (US) LLC and an officer of Prenetics Global Ltd (NASDAQ:PRE), received a grant of 10,730 Restricted Stock Units on September 3, 2026. The transaction is coded "A" (acquired) in Table II of the Form 4, with a derivative security price of $0. The RSUs were granted under the issuer's 2022 Share Incentive Plan, and the filing states that each RSU "represents a contingent right to receive one Class A Ordinary Share."

The filing details a two-part vesting schedule, both portions subject to continued service. The first tranche of 3,576 RSUs vests on August 3, 2027. The second tranche of 7,154 RSUs vests in eight equal installments on the third day of every third month following August 3, 2027, starting November 3, 2027 and concluding on August 3, 2029. The filing states that "upon vesting, the RSUs are settled and delivered in shares." The expiration date for the derivative securities is listed as August 3, 2033.

The Form 4 was signed by Stephen Hoi Chun Lo as attorney-in-fact for Thuan Yen Tat and filed on September 4, 2026. No entries appear in Table I (Non-Derivative Securities), indicating the disclosed transaction involves only the derivative security. Following the transaction, the reporting person directly holds 10,730 derivative securities.

What Was Disclosed

Prenetics Global Ltd officer Tat Thuan Yen reported the acquisition of 10,730 RSUs at $0, granted September 3, 2026 under the company's 2022 Share Incentive Plan, with vesting between August 2027 and August 2029, subject to continued service.